• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Novartis

Novartis

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Global Aplastic Anemia Therapeutics Pipeline Report 2016 - Review of 8 Companies & Drug Profiles - Research and Markets

    Global Aplastic Anemia Therapeutics Pipeline Report 2016 - Review of 8 Companies & Drug Profiles - Research and Markets

  2. Global Insomnia Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Eisai, Evotec, Novartis - Research and Markets

    Global Insomnia Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Eisai, Evotec, Novartis - Research and Markets

  3. Global Hairy Cell Leukemia Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: AstraZeneca, MedImmune, Novartis - Research and Markets

    Global Hairy Cell Leukemia Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: AstraZeneca, MedImmune, Novartis - Research and Markets

  4. Hormone Replacement Therapy (HRT) - Global Strategic Business Report 2016-2022: Amid Controversies, Confusion and Competition, Demand for HRT Continues to Rise - Research and Markets

    Hormone Replacement Therapy (HRT) - Global Strategic Business Report 2016-2022: Amid Controversies, Confusion and Competition, Demand for HRT Continues to Rise - Research and Markets

  5. Global Age-Related Macular Degeneration (AMD) Market Growth of 7.6% CAGR by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Acucela, Bayer, Novartis - Research and Markets

    Global Age-Related Macular Degeneration (AMD) Market Growth of 7.6% CAGR by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Acucela, Bayer, Novartis - Research and Markets

  6. Global Small-Cell Lung Cancer Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts - Key Vendors: 4SC, Amgen, Johnson & Johnson - Research and Markets

    Global Small-Cell Lung Cancer Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts - Key Vendors: 4SC, Amgen, Johnson & Johnson - Research and Markets

  7. $39.4 Billion Biomarkers Report: Technologies and Global Markets to 2020 - Research and Markets

    $39.4 Billion Biomarkers Report: Technologies and Global Markets to 2020 - Research and Markets

  8. World Market for Companion Diagnostic Tests 2015-2020 - Research and Markets

    World Market for Companion Diagnostic Tests 2015-2020 - Research and Markets

  9. Why Are Primecap Funds So Sustainable?

    These Gold-rated funds have Morningstar Sustainability Ratings of High despite not explicitly trying to do so.

  10. Global Oropharyngeal Cancer Pipeline Report 2016 - Research and Markets

    Global Oropharyngeal Cancer Pipeline Report 2016 - Research and Markets

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.